Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what funding he has made available for research into neurofibromatosis type 1 in the last five years.
Expenditure by the Department’s National Institute for Health Research (NIHR) on neurofibromatosis type 1 research through research programmes, research centres and units, and research fellowships is shown in the following table.
£ million
2009-10 | 2010-11 | 2011-12 | 2012-13 | 2013-14 |
0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
The NIHR welcomes funding applications for research into any aspect of human health, including neurofibromatosis type 1. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. In all disease areas, the amount of NIHR funding depends on the volume and quality of scientific activity.